ZFYVE26

protein-coding

zinc finger FYVE-type containing 26, the group of Zinc fingers FYVE-type

Gene summary

This gene encodes a protein which contains a FYVE zinc finger binding domain. The presence of this domain is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15. [provided by RefSeq, Oct 2008]

Previous symbols:
  • SPG15

MANE transcript

NM_015346.4

Inheritance

AR

ClinVar variants

P:422U:812B:1058

Top phenotype

Spastic paraplegia 15, autosomal recessive

gnomAD constraint

pLI —, LoF o/e 0.48

Max pathogenic AF

—

Genomic locus

chr14:67,727,374-67,816,590

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~89.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

hereditary spastic paraplegia 15SUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0010044

Submitter: Orphanet

hereditary spastic paraplegia 15DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0010044

Submitter: G2P

hereditary spastic paraplegia 15STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0010044

Submitter: Labcorp Genetics (formerly Invitae)

hereditary spastic paraplegia 15STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0010044

Submitter: PanelApp Australia

hereditary spastic paraplegia 15DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0010044

Submitter: Myriad Women's Health

Clinical Genomic Database (CGD)

Spastic paraplegia 15, autosomal recessiveAR

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 11342696; 14745065; 17661097; 19438933; 18394578; 19805727Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ZFYVE26 variants in ClinVar

14 Conditions Cataloged
Spastic paraplegiaTotal: 2258
not providedTotal: 466
Hereditary spastic paraplegia 15Total: 420
Inborn genetic diseasesTotal: 367
Hereditary spastic paraplegiaTotal: 110
not specifiedTotal: 86
ZFYVE26-related disorderTotal: 31
Tip-toe gaitTotal: 4

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_015346.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
15
clinvar
990
clinvar
14
clinvar
1021
missense
2
clinvar
14
clinvar
784
clinvar
46
clinvar
8
clinvar
854
nonsense
82
clinvar
62
clinvar
4
clinvar
148
start loss
1
clinvar
1
frameshift
91
clinvar
91
clinvar
2
clinvar
184
splice donor/acceptor (+/-2bp)
7
clinvar
70
clinvar
7
clinvar
84
Total1832398121036222292

Highest pathogenic variant AF is 0.00008735962

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 17 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_015346.4RefSeqNP_056161.241MANE Select
ENST00000347230.9EnsemblENSP00000251119.541MANE Select
ENST00000554557.5EnsemblENSP00000450431.18Standard
ENST00000555452.1EnsemblENSP00000450603.134Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
zfyve26Danio rerio

Structure: motor neuron

Quality: branchiness

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • mitotic cytokinesis
  • double-strand break repair via homologous recombination
  • regulation of cytokinesis

Molecular Function

  • protein binding
  • phosphatidylinositol-3-phosphate binding
  • metal ion binding

Cellular Component

  • lysosomal membrane
  • centrosome
  • midbody

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000347230
Coding exons
41
Length
89217
Individuals with no LoFs
125614
Homozygous LoFs
0
Heterozygous LoFs
134
Defined
125748
p
0.000533
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.52012801.33e+30.9600.000077516499
Missense (PolyPhen)314382.620.820655122
Synonymous0.5115215360.9720.00003015150
Loss of Function5.23581200.4840.000006241427

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000430.00043rare
Latino/Admixed American0.000380.00038rare
Ashkenazi Jewish0.000300.00030rare
East Asian0.000430.00044rare
Finnish0.000280.00028rare
European (Non-Finnish)0.000690.00069rare
South Asian0.000590.00059rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Phosphatidylinositol 3-phosphate-binding protein required for the abcission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abcission. May also be required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20208530}.;
Disease
DISEASE: Spastic paraplegia 15, autosomal recessive (SPG15) [MIM:270700]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or mental retardation, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration. {ECO:0000269|PubMed:18394578, ECO:0000269|PubMed:19084844, ECO:0000269|PubMed:19805727}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.105

Intolerance Scores

LoFtool
0.892
RVIS EVS
-0.27
RVIS percentile EVS
33.59

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.397

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.